174 related articles for article (PubMed ID: 12469693)
1. Sirolimus: new preparation. No tangible advance in renal transplantation.
Prescrire Int; 2002 Dec; 11(62):165-6. PubMed ID: 12469693
[TBL] [Abstract][Full Text] [Related]
2. Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine.
Kahan BD
Transplant Proc; 2008 Dec; 40(10 Suppl):S17-20. PubMed ID: 19100899
[TBL] [Abstract][Full Text] [Related]
3. Median effect analysis of efficacy versus adverse effects of immunosuppressants.
Kahan BD; Kramer WG
Clin Pharmacol Ther; 2001 Jul; 70(1):74-81. PubMed ID: 11452247
[TBL] [Abstract][Full Text] [Related]
4. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
5. Considerations in sirolimus use in the early and late post-transplant periods.
Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO
Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662
[TBL] [Abstract][Full Text] [Related]
6. Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity.
Campistol JM; Grinyó JM
Transplantation; 2001 Jun; 71(11 Suppl):SS42-51. PubMed ID: 11583488
[TBL] [Abstract][Full Text] [Related]
7. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
Chapman JR; Nankivell BJ
Nephrol Dial Transplant; 2006 Aug; 21(8):2060-3. PubMed ID: 16728428
[No Abstract] [Full Text] [Related]
8. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus in pediatric patients: results in the first 6 months post-renal transplant.
Hymes LC; Warshaw BL
Pediatr Transplant; 2005 Aug; 9(4):520-2. PubMed ID: 16048606
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus, a new potent immunosuppressant agent for refractory cardiac transplantation rejection: two case reports.
Haddad H; MacNeil DM; Howlett J; O'Neill B
Can J Cardiol; 2000 Feb; 16(2):221-4. PubMed ID: 10694593
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.
Cowan PA; Heizer KE
Nephrol Nurs J; 2000 Dec; 27(6):623-5. PubMed ID: 16649344
[TBL] [Abstract][Full Text] [Related]
13. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
Oberbauer R; Kreis H; Johnson RW; Mota A; Claesson K; Ruiz JC; Wilczek H; Jamieson N; Henriques AC; Paczek L; Chapman J; Burke JT;
Transplantation; 2003 Jul; 76(2):364-70. PubMed ID: 12883194
[TBL] [Abstract][Full Text] [Related]
14. Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation.
Bhorade S; Ahya VN; Baz MA; Valentine VG; Arcasoy SM; Love RB; Seethamraju H; Alex CG; Bag R; Deoliveira NC; Husain A; Vigneswaran WT; Charbeneau J; Krishnan JA; Durazo-Arvizu R; Norwick L; Garrity E
Am J Respir Crit Care Med; 2011 Feb; 183(3):379-87. PubMed ID: 20833822
[TBL] [Abstract][Full Text] [Related]
15. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
16. [Immunosuppression with sirolimus so donor kidneys survive longer].
MMW Fortschr Med; 2004 Aug; 146(31-32):46-7. PubMed ID: 15529711
[No Abstract] [Full Text] [Related]
17. Sirolimus in kidney transplantation from marginal donors.
Pisani F; Buonomo O; Iaria G; Iorio B; Rizzello A; Pollicita S; De Luca L; Valeri M; Boffo V; Famulari A; Casciani CU
Transplant Proc; 2004 Apr; 36(3):495-6. PubMed ID: 15110569
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus in the prevention of graft rejection: new indication. Helpful alternative to ciclosporin.
Prescrire Int; 1998 Aug; 7(36):108-9. PubMed ID: 10342948
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus (Rapamune) for transplant rejection.
Med Lett Drugs Ther; 2000 Feb; 42(1071):13-4. PubMed ID: 10725969
[No Abstract] [Full Text] [Related]
20. Sirolimus-based immunosuppression: present state of the art.
Kahan BD
J Nephrol; 2004; 17 Suppl 8():S32-9. PubMed ID: 15599884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
